Z Squared CEO Michelle Burke resigns, David Halabu becomes sole CEO

Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc.

COEP

0.00

  • Michelle Burke resigned as co-chief executive officer and a director, effective May 22, 2026.
  • David Halabu will continue as sole chief executive officer, effective May 22, 2026.
  • Halabu has served as co-CEO since April 24, 2026, and has led operating subsidiary Z Squared OpCo as CEO since June 2024.
  • His background includes trading and investment roles, including heading a trading desk at Assent, co-founding Group 10 Capital Management, and working on capital markets and strategy at Broadstreet.
  • No successor has been named to fill the board vacancy.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Z Squared Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-004273), on May 22, 2026, and is solely responsible for the information contained therein.